Salvia BioElectronics
PrivateLast Round
Series B
May 27, 2025
Total Funding Raised
$98.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Salvia BioElectronics operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Series B round in May 2025.
Salvia BioElectronics is a medical device company that develops minimally invasive, ultra-thin implantable neuromodulation technology to treat chronic migraines and cluster headaches.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salvia BioElectronics Comparables
Compare Salvia BioElectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ShiraTronics | 92% | |
| Neurolief | 72% | |
| Precisis GmbH | 63% |
For institutional investors. Book with your work email.
Salvia BioElectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2025 | ||||
| Debt | Sep 22, 2020 | ||||
| Series A | Sep 22, 2020 | ||||
| Seed | May 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Salvia BioElectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B |
| SHS Gesellschaft für Beteiligungsmanagement mbH | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B, Seed |
| Dolby Family Ventures | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B |
| Invest-NL | Series B |
| My Global Family Office | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 647% MoM, reaching 11.8K.
- Jun 25, 2026
Grew 16% QoQ, from 67 to 78 employees.
For institutional investors. Book with your work email.
Salvia BioElectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Salvia BioElectronics's valuation, stock price, and market status.
Is Salvia BioElectronics a public or private company?
Salvia BioElectronics is a private company.
What is the current stock price of Salvia BioElectronics?
Salvia BioElectronics is a private company, so its shares have no public market price. Caplight tracks Salvia BioElectronics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salvia BioElectronics worth (valuation)?
Valuation information for Salvia BioElectronics is not publicly available.
Can I buy Salvia BioElectronics stock?
Salvia BioElectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salvia BioElectronics's last funding round?
Salvia BioElectronics's most recent funding round was Series B on May 27, 2025.
Who are the main investors in Salvia BioElectronics?
Key investors in Salvia BioElectronics include SHS Gesellschaft für Beteiligungsmanagement mbH, Brabantse Ontwikkelings Maatschappij, Panakès Partners, Inkef Capital, Innovation Industries.
Will Salvia BioElectronics IPO soon?
No public IPO plans have been announced for Salvia BioElectronics.
How can I track Salvia BioElectronics secondary market activity?
Caplight tracks bids, offers, and trades in Salvia BioElectronics's shares on secondary markets.